Cerebellum’s CME Group CME Stock Holding History

Cerebellum’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,000	Closed	-$329K	–	444
2019 Q1	$329K	Buy	2,000 +646	+48%	+$114K	0.29%	163
2018 Q4	$255K	Buy	+1,354	New	+$250K	0.18%	149

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cerebellum's CME Position: Q2 2019 in Review

Cerebellum sold out of CME Group (CME) in Q2 2019, closing a stake of 2,000 shares — an estimated $329K sold.

Cerebellum first reported a position in CME in Q4 2018 and held it in 2 quarters. The position peaked at $329K in Q1 2019. 978 funds tracked by Wall St. Rank hold CME as of Q2 2019.

Cerebellum reported no remaining CME Group position as of Q2 2019 after selling out during the quarter.
Cerebellum sold 2,000 CME Group shares in Q2 2019, an estimated $329K.
Cerebellum first reported a position in CME Group in Q4 2018 and held it in 2 quarters.
Cerebellum's CME Group position peaked at $329K in Q1 2019.
978 funds tracked by Wall St. Rank held CME Group as of Q2 2019.

Based on Cerebellum's 13F filing for Q2 2019, filed 19 Jul 2019.